Open AccessSpeed of recovery in adult patients with community-acquired pneumonia; moxifloxacin versus levofloxacin
Author(s) -
Jamal Wadi Al Ramahi,
Mustafa Ramadan,
Waad Jaber,
Lamya Abushanab,
Mohammad Mughrabi,
Noor Alshamayleh,
Ahmad Mulhem,
Dania Al Momani,
Mohammad M. Obaidat,
Ghayda Haddad,
Basma M. Khalil,
Anas Zahran,
Esraa Odat,
Nadeen Kufoof,
Haneen Arabiat,
Amr Diab,
Antonio Anzueto
Publication year - 2018
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.10335
Subject(s) - moxifloxacin , levofloxacin , pneumonia , medicine , community acquired pneumonia , intensive care medicine , microbiology and biotechnology , antibiotics , biology
To evaluate the speed of recovery in CAP-treated adults with Moxifloxacin versus levofloxacin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom